Arcadis NV (ARCAD.AS)
| Previous close | 59.85 |
| Open | 60.20 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 60.00 - 60.40 |
| 52-week range | 36.86 - 62.70 |
| Volume | |
| Avg. volume | 214,151 |
| Market cap | 5.457B |
| Beta (5Y monthly) | 1.08 |
| PE ratio (TTM) | 33.74 |
| EPS (TTM) | 1.78 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 0.85 (1.42%) |
| Ex-dividend date | 10 May 2024 |
| 1y target est | 64.00 |
Simply Wall St.Top 3 Stocks Estimated To Be Undervalued On Euronext Amsterdam In June 2024
As European markets show signs of recovery with easing political uncertainties and a brighter monetary policy outlook, investors are turning their attention to potentially undervalued opportunities. In this context, identifying stocks on the Euronext Amsterdam that appear undervalued could be particularly timely for those looking to diversify or enhance their portfolios in June 2024.
- Simply Wall St.
Exploring Undervalued Stocks On Euronext Amsterdam With Intrinsic Discounts Ranging From 19% To 49.2%
As global markets exhibit varied responses to economic signals, the Netherlands' stock market presents unique opportunities for investors seeking value. In light of current market conditions, identifying stocks that appear undervalued relative to their intrinsic worth could be particularly compelling.
- Simply Wall St.
Euronext Amsterdam Insights: Three Stocks Estimated To Be Below Their Fair Value In June 2024
As European markets show signs of recovery with indices like the STOXX Europe 600 gaining ground, investors are keenly observing shifts and opportunities within specific markets such as the Netherlands. In this context, identifying stocks that are potentially undervalued becomes particularly compelling, especially when considering how broader economic indicators and market movements can influence individual stock performance.
